Head of Microbial Expression Delivery

Novo Nordisk A/S; Måløv; Remote; DKK 847,000 - 1,245,000; Full time

Job summary

Novo Nordisk A/S in Denmark seeks an Associate Director to build and lead Microbial Expression Delivery, centralising automated expression technologies and ensuring timely protein deliveries for the portfolio.

You will direct a team of twelve scientists and technicians, translate portfolio priorities into clear direction, and foster an inclusive culture that drives scientific excellence and impact for patients with serious chronic diseases.

Qualifications

• Advanced degree in molecular biology/biotech/biochemistry or related field.
• People leadership experience with collaboration across functions.
• Experience with microbial expression of proteins/peptides and LC-MS workflows.
• Experience in a matrixed organization with clear prioritization and expectations.
• Collaborative, inclusive leadership with clear direction and respect.

Responsibilities

• Establish Microbial Expression Delivery as a new department centralising automated expression technologies.
• Oversee centralised platforms including LC-MS and high-throughput workflows with clear accountability.
• Translate portfolio priorities into direction for the team balancing capacity and stakeholder needs.
• Strengthen handovers with other CEE departments and internal partners.
• Remove barriers across Therapeutic Discovery to speed decisions and align priorities.
• Lead by example, fostering a respectful, open culture where people grow.

Skills

People leadership

Microbial expression

LC-MS workflows

Cross-functional collaboration

Clear priorities

Education

Advanced degree in molecular biology/biotechnology/biochemistry or related field

Tools

LC-MS

Automation workflows

Job description

Novo Nordisk A/S in Denmark seeks an Associate Director to build and lead Microbial Expression Delivery, centralising automated expression technologies and ensuring timely protein deliveries for the portfolio.

You will direct a team of twelve scientists and technicians, translate portfolio priorities into clear direction, and foster an inclusive culture that drives scientific excellence and impact for patients with serious chronic diseases.